Therapeutic Strategies in HER2 Breast Cancer - Pertuzumab, Neratinib and T-DM1 Therapy
Therapeutic Strategies in HER2 Breast Cancer - Pertuzumab, Neratinib and T-DM1 Therapy
Apr 27, 2019
vumedi.com
Upfront T-DM1 in HER2-Positive Breast Cancer
4:33
Upfront T-DM1 in HER2-Positive Breast Cancer
800 viewsNov 13, 2014
YouTubeOncLive
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
0:57
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
828 viewsOct 1, 2012
YouTubeOncLive
Update from KATHERINE on Adjuvant T-DM1 for Residual Invasive HER2 Early Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
3:27
Update from KATHERINE on Adjuvant T-DM1 for Residual Invasive HER2 Early Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Jan 11, 2024
targetedonc.com
Dr. Esteva Discusses T-DM1 in HER2-Positive Breast Cancer
2:00
Dr. Esteva Discusses T-DM1 in HER2-Positive Breast Cancer
471 viewsJun 22, 2015
YouTubeOncLive
T-DXd Versus T-DM1 in HER2 MBC: Results of DESTINY-Breast03 | OncLive
T-DXd Versus T-DM1 in HER2 MBC: Results of DESTINY-Breast03 | OncLive
Oct 28, 2021
onclive.com
T-DM1 Breast Cancer Drug
5:40
T-DM1 Breast Cancer Drug
1.8K viewsNov 10, 2015
YouTubeBreast Cancer Answers®
LBA1 - Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with high-risk human epidermal growth factor receptor 2–positive (HER2 ) primary breast cancer (BC) with residual invasive disease after neoadjuvant therapy (tx): Interim analysis of DESTINY-Breast05 | OncLive
6 months ago
onclive.com
New breast cancer drug unveiled
Oct 4, 2012
channel4.com
4:19
ASCO: New Treatment (T-DM1) for HER2-Positive Advanced Breast Cancer?
4.5K viewsJun 3, 2012
YouTubeMDedge: news and insights for busy physicians
4:04
Neoadjuvant T-DM1 in HER2+ Early Breast Cancer
336 viewsNov 10, 2016
YouTubeOncLive
1:55
Benefit of Antibody Drug Conjugate T-DM1 in HER2+ BC
369 viewsMay 23, 2019
YouTubeTargeted Oncology
Fitting T-DM1 Into Established Upfront Treatment Paradigms
4:26
Fitting T-DM1 Into Established Upfront Treatment Paradigms
85 viewsDec 19, 2014
YouTubeOncLive
3:15
What Is T-DM1 And How Does It Fight HER2-positive Breast Cancer? - Breast Cancer Support Channel
15 views6 months ago
YouTubeBreast Cancer Support Channel
Treating Early HER2+ Breast Cancer: KATHERINE
6:53
Treating Early HER2+ Breast Cancer: KATHERINE
634 viewsAug 7, 2020
YouTubeTargeted Oncology
Dr. Burris Discusses Promise of T-DM1 in HER2+ Breast Cancer
1:09
Dr. Burris Discusses Promise of T-DM1 in HER2+ Breast Cancer
171 viewsFeb 4, 2019
YouTubeOncLive
3:21
How Breast Cancer Treatment Kadcyla (T-DM1) Works
5.2K viewsNov 3, 2017
YouTubeLighter Side of Cancer
3:29
DESTINY-Breast05: T-DXd vs T-DM1 in high-risk HER2+ early breast cancer
327 views6 months ago
YouTubeVJOncology
2:05
Duke Cancer Institute's Dr. Kimberly Blackwell Discusses New Treatment for Breast Cancer
3.2K viewsJun 27, 2012
YouTubeDukeCancerInstitute
ASCO® 2024 Insights: "Updated Survival Data in DESTINY-Breast03 Trial - T-DXd vs. T-DM1 in Patients With HER2 mBC"
435 viewsJun 18, 2024
vumedi.com
0:52
Dr. Julie Gralow Discusses the Antibody Drug Conjugate T-DM1 for Breast Cancer
293 viewsSep 4, 2012
YouTubeOncLive
7:45
Trastuzumab Emtansine in HER2+ Breast Cancer
1.7K viewsJul 7, 2020
YouTubeTargeted Oncology
20:17
S1 Episode 1: Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and Toxicity
5.7K viewsAug 20, 2024
YouTubeMedscape
2:02
KATHERINE Trial: T-DM1 cuts HER2-positve invasive breast cancer recurrence
3.2K viewsDec 12, 2018
YouTubeMDedge: news and insights for busy physicians
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
Aug 5, 2022
mskcc.org
Dr Ostwal on T-DM1 in Pretreated HER2 Advanced Biliary Tract Cancer | OncLive
Jan 30, 2025
onclive.com
ESMO Breast 2025 Insights: Re-Shuffling the Deck - The Role of T-DM1 and TKIs After T-DXd in mBC
146 views11 months ago
vumedi.com
53:49
Management of Her 2 Positive Early Breast Cancer
448 views3 months ago
YouTubeDrJoeDrugClub
11:33
HER2CLIMB-02: Primary Analysis of a Randomized, Double-blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-positive Metastatic Breast Cancer | OncLive
Jan 25, 2024
onclive.com
Understanding Your Breast Tumor Size and Stage
7 months ago
verywellhealth.com
See more
Static thumbnail place holder